Adma Biologics | ADMA - Bénéfice Avant Impôts

Prix De L'Action
9.70
Variation Quotidienne
-0.24 -2.41%
Mensuellement
-38.10%
Annuel
-50.00%
Q2 Prévisions
9.44




Bénéfice Avant Impôts Changement Date
Adma Biologics USD 61.59M 14.07M 2025-12
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
Minerva Neurosciences USD 22.51M 30.74M 2024-09
Novavax USD 17.9M 220.94M 2025-12
Omeros USD -65.12M 21.27M 2024-06
Takeda JPY 133.86B 105.69B 2025-12